102 papers
Understanding the human mind and treating mental health conditions requires a deep blend of biological insight and behavioral science. This category explores the cutting-edge research shaping how we diagnose and treat psychiatric disorders, from depression and anxiety to complex neurological conditions. Here, you will find the latest discoveries that bridge the gap between clinical observation and molecular mechanisms, offering fresh perspectives on patient care and therapeutic innovation.
Gist.Science brings these vital studies directly to you by monitoring medRxiv, the leading preprint server for health sciences. As soon as new manuscripts appear in this field, our team processes them to provide both accessible plain-language summaries and detailed technical overviews. This ensures that complex findings are understandable for everyone, from curious readers to busy professionals who need quick, accurate insights without wading through dense academic prose.
Below are the most recent psychiatry and clinical psychology preprints, curated and summarized to keep you informed on the evolving landscape of mental health research.
This cross-sectional study of 967 Mexican participants seeking online psychological support utilized network analysis to identify self-evaluation and emotional well-being as central elements linking mental well-being with distress and psychological inflexibility, thereby highlighting key targets for intervention.
This multiverse analysis of two large datasets reveals that the theta/beta ratio is not a robust biomarker for ADHD, as previously reported group differences are largely driven by analytical choices, age, and individual alpha frequency rather than stable oscillatory dynamics.
This quasi-experimental study demonstrates that the internet-based cognitive behavioral therapy program MoodGYM significantly reduces depressive symptoms among repeating undergraduate students at the University of Zambia, offering a scalable mental health solution for low-resource university settings.
This study demonstrates that a plasma cytokine panel, specifically elevated IL-17A combined with lower MIP-3α and IFN-γ levels, serves as a strong predictive biomarker for identifying first-episode psychosis patients at risk of clinical stage transition over a 12-month period.
This study demonstrates that baseline white blood cell count moderates the relationship between heart-brain coupling during iTBS and clinical improvement in major depression, where higher coupling predicts symptom relief only in patients with lower inflammation, while elevated white blood cell counts are associated with specific white-matter microstructural alterations and reduced treatment efficacy.
This study demonstrates that DNA methylation profiles in very preterm children, particularly during the neonatal period, are significantly associated with social-behavioral outcomes at age 5, implicating specific neurodevelopmental genes and pathways in the biological link between preterm birth and later behavioral challenges.
This mixed-methods study identifies four distinct population groups with varying mental health needs in Australian prisons and outlines the specific service mixes required for each to support evidence-based, equitable, and responsive mental health care planning within custodial environments.
This study protocol outlines a cluster-randomized trial designed to conceptually replicate the efficacy of the Homework, Organization, and Planning Skills (HOPS) program for youth aged 11–14 by evaluating its effectiveness when delivered by school-based providers compared to treatment-as-usual/waitlist and research team providers under authentic post-pandemic conditions.
This meta-analysis of 227 individuals across three cohorts demonstrates that early-life adversity leaves a common DNA methylation signature involving 15 genes related to neuronal development and metabolism, which can be quantified using a newly developed poly-epigenetic score to track long-term health impacts.
Using unsupervised machine learning on UK Biobank data, this study identifies robust and reproducible symptom subtypes of depression that align with known clinical categories and reveal novel profiles linked to specific sociodemographic factors, health conditions, and genetic risks, thereby supporting data-driven approaches for refining diagnosis and personalizing treatment.